Evergreen Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Evergreen Private Wealth's BMY Position: Q4 2025 in Review
Evergreen Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 1,058 shares — an estimated $47.7K sold.
Evergreen Private Wealth first reported a position in BMY in Q4 2023 and held it in 8 quarters. The position peaked at $86.8K in Q4 2023. 2,455 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Evergreen Private Wealth reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Evergreen Private Wealth sold 1,058 Bristol-Myers Squibb shares in Q4 2025, an estimated $47.7K.
- Evergreen Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 8 quarters.
- Evergreen Private Wealth's Bristol-Myers Squibb position peaked at $86.8K in Q4 2023.
- 2,455 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Evergreen Private Wealth's 13F filing for Q4 2025, filed 28 Jan 2026.